This multicenter observational study will evaluate the use of RoActemra/Actemra (tocilizumab) in monotherapy in patients with active moderate to severe rheumatoid arthritis unable to use methotrexate....

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Active, not recruiting - verified February 2014

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Active, not recruiting - verified November 2013

This multicenter observational study will evaluate the use of RoActemra/Actemra (tocilizumab) in monotherapy in patients with active moderate to severe rheumatoid arthritis unable to use methotrexate....

Condition : Osteoarthritis Intervention : Sponsors : Massachusetts General Hospital; MAKO Surgical Corp. Withdrawn - verified November 2013

Condition : Arthritis, Rheumatoid Interventions : Drug: BI 695500; Drug: BI 695500; Drug: rituximab; Drug: rituximab; Drug: rituximab Sponsor : Boehringer Ingelheim Recruiting - verified February 2014

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Active, not recruiting - verified February 2014

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Active, not recruiting - verified November 2013

Condition : Arthritis, Rheumatoid Interventions : Drug: BI 695500; Drug: BI 695500; Drug: rituximab; Drug: rituximab; Drug: rituximab Sponsor : Boehringer Ingelheim Pharmaceuticals Recruiting - verifi...

Conditions : Osteoarthritis of Hip; Failure of Primary THA Intervention : Procedure: Bead placement during revision hip replacement surgery Sponsor : Massachusetts General Hospital Withdrawn - verifie...